News

Filter

Current filters:

Imitrex

1 to 9 of 115 results

India’s Dr Reddy’s posts unexpected 3rd-qtr loss, revises forecasts

21-01-2010

India’s second largest drugmaker Dr Reddy’s Laboratories surprised investors yesterday, by…

Asia-PacificFinancialGenericsGlaxoSmithKlineGSKImitrexPharmaceuticalSumatriptan Succinate

US FDA approves Ranbaxy’s generic sumatriptan

11-08-2009

The US subsidiary of Indian drugmaker Ranbaxy has received final approval from the U. Food and Drug Administration…

GenericsGlaxoSmithKlineGSKImitrexNorth AmericaSumatriptan Succinate

Dr Reddy's falls to loss on goodwill adjustment

01-06-2009

India-based generics major Dr Reddy's Laboratories has fallen into loss for the 12 months to March 31,…

Dr Reddy's LaboratoriesGlaxoSmithKlineGSKImitrexSumatriptan Succinate

MAP shares surge 192% as migraine drug Levadex meets late-stage study endpoints

28-05-2009

MAP Pharmaceuticals' orally-inhaled migraine drug Levadex (dihydroergotamine) met all four primary endpoints…

AstraZenecaD. H. E. 45DihydroergotamineGlaxoSmithKlineGSKImitrexNystatinOralSumatriptan SuccinateZolmitriptanZomig

1 to 9 of 115 results

COMPANY SPOTLIGHT

Menarini

Back to top